dabl® News - dabl Clinical Trials

Hypertension and Chronic Obstructive Pulmonary Disease (COPD)
21 Nov 2018

Hypertension is a condition that prevails globally and is estimated to affect over one billion people. It occurs irrespective of income status but is more common with advancing age. Physical inactivity and increasing body weight are significant contributory factors to developing hypertension. On this, #WorldCOPDDay it is worth noting the correlation between COPD, hypertension and […]

{...} click to continue

Clinical Trials are a Waste of Time and Money – Are They?
15 Nov 2018

The cost of clinical trials is rising exponentially. The Tufts Centre for the Study of Drug Development has published data that indicates the average cost to develop and secure marketing approval for a new drug now exceeds $2.5 billion. Although the new industry model of outsourcing, in the form of Contract research Organisations, is seen as a step […]

{...} click to continue

How are diabetes and hypertension linked?
14 Nov 2018

Hypertension, otherwise known as Blood Pressure can affect people with Type 1 or Type 2 Diabetes. In most cases Hypertension has no signs or symptoms and this is why it is often referred to as the silent killer. According to the American Diabetes Association 71% of adults with diabetes had a blood pressure of greater than […]

{...} click to continue

ISO 9001:2015 Certification
25 Oct 2018

Press Release – October 2018 – Dublin dabl Ltd, a globally recognised provider of Centralised Blood Pressure Data Management Systems for Clinical Trials, announces it is certified under ISO 9001: 2015. ISO 9001 is the international standard for a Quality Management System. It ensures that we consistently provide products and services that meet customer and […]

{...} click to continue